| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |